Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China
· Delayed Price · Currency is CNY 23.00
-0.20 (-0.86%)
Apr 29, 2026, 3:00 PM CST
Aurisco Pharmaceutical Revenue
Aurisco Pharmaceutical had revenue of 389.26M CNY in the quarter ending March 31, 2026, a decrease of -3.17%. This brings the company's revenue in the last twelve months to 1.68B, up 9.25% year-over-year. In the year 2025, Aurisco Pharmaceutical had annual revenue of 1.70B with 15.03% growth.
Revenue (ttm)
1.68B
Revenue Growth
+9.25%
P/S Ratio
5.56
Revenue / Employee
944.36K
Employees
1,784
Market Cap
9.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.70B | 221.74M | 15.03% |
| Dec 31, 2024 | 1.48B | 213.21M | 16.89% |
| Dec 31, 2023 | 1.26B | 254.45M | 25.24% |
| Dec 31, 2022 | 1.01B | 204.71M | 25.48% |
| Dec 31, 2021 | 803.36M | 81.92M | 11.36% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.84B |
| Liaoning Chengda Biotechnology | 1.39B |
| Beijing Hotgen Biotech | 404.88M |
| Jiangxi Fushine Pharmaceutical | 1.18B |
| Bio-Thera Solutions | 933.69M |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 1.94B |
| Shanghai Medicilon | 1.16B |
| Sino Biological,Inc. | 699.56M |